Lexicon Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Lexicon Pharmaceuticals's past years’ income statements indicate that its last revenue has increased compared to the previous period by 766% to $1,204,000. Profit margin reached -14711%. Total operating expenses were $172,869,000.
Profit Margin
| 2014 | 22.85M | -100.29M | -438.85% |
|---|---|---|---|
| 2015 | 130.01M | -4.68M | -3.6% |
| 2016 | 83.33M | -141.42M | -169.71% |
| 2017 | 90.33M | -129.05M | -142.86% |
| 2018 | 63.20M | -120.54M | -190.71% |
| 2019 | 322.07M | 130.13M | 40.4% |
| 2020 | 23.99M | -70.18M | -292.49% |
| 2021 | 298K | -88.26M | -29620.13% |
| 2022 | 139K | -103.12M | -74192.81% |
| 2023 | 1.20M | -177.11M | -14710.88% |
LXRX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 1.20M | 139K | 298K | 23.99M | 322.07M | 63.20M | 90.33M | 83.33M | 130.01M | 22.85M |
Cost of revenue | 85K | 427K | 55.04M | 1.92M | 3.23M | 2.49M | 1.89M | 0 | 95.18M | 89.27M |
Gross profit | 1.11M | -288K | -54.74M | 22.06M | 318.84M | 60.71M | 88.43M | 83.33M | 34.82M | -66.42M |
Operating exp. | ||||||||||
Research and development | 58.88M | 52.81M | 55.04M | 153.62M | 91.92M | 100.24M | 156.81M | 178.15M | 95.18M | 89.27M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 172.86M | 100.89M | 87.38M | 200.85M | 148.75M | 163.99M | 223.01M | 221.19M | 119.02M | 108.69M |
Operating income | -171.75M | -100.76M | -87.09M | -178.78M | 141.44M | -103.27M | -136.68M | -137.15M | 1.46M | -100.36M |
Other income (expenses), net | -5.36M | -1.18M | -668K | -10.77M | -17.32M | -17.26M | -5.03M | 703K | -6.15M | 2K |
Income before tax | -177.11M | -101.94M | -87.75M | -58.57M | 124.11M | -120.54M | -141.71M | -141.42M | -4.68M | -100.36M |
Income tax expense | 0 | 1.18M | 510K | 11.61M | -6.01M | 3.50M | -12.66M | 4.51M | 5.99M | -70K |
Net income | -177.11M | -103.12M | -88.26M | -70.18M | 130.13M | -120.54M | -129.05M | -141.42M | -4.68M | -100.29M |
Earnings per share | ||||||||||
Basic EPS | -0.8 | -0.62 | -0.61 | -0.63 | 1.23 | -1.14 | -1.23 | -1.36 | -0.04 | -1.31 |
Diluted EPS | -0.8 | -0.62 | -0.61 | -0.63 | 1.11 | -1.14 | -1.23 | -1.36 | -0.04 | -1.31 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |